News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clarivate Analytics Plc
(NY:
CLVT
)
6.960
+0.080 (+1.16%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clarivate Analytics Plc
< Previous
1
2
3
4
5
6
7
Next >
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023
August 25, 2023
Via
Benzinga
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
August 22, 2023
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What 5 Analyst Ratings Have To Say About Clarivate
July 05, 2023
Via
Benzinga
12 Industrials Stocks Moving In Monday's After-Market Session
August 21, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023
August 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
August 04, 2023
Via
Benzinga
Where Clarivate Stands With Analysts
June 13, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 04, 2023
On Friday, 73 companies reached new 52-week lows.
Via
Benzinga
12 Industrials Stocks Moving In Thursday's Intraday Session
August 03, 2023
Via
Benzinga
Analyst Expectations for Clarivate's Future
May 10, 2023
Via
Benzinga
The Latest Analyst Ratings for Clarivate
March 10, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Expert Ratings for Clarivate
January 04, 2023
Via
Benzinga
Clarivate Is Oversold Stock Brimming with Turnaround Potential, Analyst Predicts
June 13, 2023
Oppenheimer analyst Owen Lau initiates coverage on Clarivate Plc (NYSE: CLVT) with an Outperform rating and
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
June 13, 2023
Via
Benzinga
12 Industrials Stocks Moving In Wednesday's Intraday Session
March 01, 2023
Via
Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
March 01, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Expert Ratings for Clarivate
November 09, 2022
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
May 08, 2023
On Monday, 61 companies hit new 52-week lows.
Via
Benzinga
Where Clarivate Stands With Analysts
November 09, 2022
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Analyst Ratings for Clarivate
October 07, 2022
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
5 Analysts Have This to Say About Clarivate
September 13, 2022
Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter:
Via
Benzinga
What 5 Analyst Ratings Have To Say About Clarivate
August 10, 2022
Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter:
Via
Benzinga
Recap: Clarivate Q2 Earnings
August 09, 2022
Clarivate (NYSE:CLVT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Singapore's National Library Board Picks Clarivate's Software Solutions To Support LAB25 Initiative
August 08, 2022
Via
Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 01, 2023
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via
Benzinga
Morgan Stanley Maintains Overweight Rating for Clarivate: Here's What You Need To Know
September 13, 2022
Morgan Stanley has decided to maintain its Overweight rating of Clarivate (NYSE:CLVT) and lower its price target from $16.00 to $15.00. Shares of Clarivate are trading down 2.75% over the last 24...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
February 06, 2023
Via
Benzinga
12 Industrials Stocks Moving In Monday's Pre-Market Session
August 08, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
July 13, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.